CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-01 | Stromatt Scott C Chief Medical Officer and SVP | Shares withheld for taxes | −4,823 | $1.57 | $8K | 216,183 |
| 2019-03-01 | Stromatt Scott C Chief Medical Officer and SVP | Option exercise · Restricted Stock Unit | −16,269 | 0 | ||
| 2019-03-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise | +6,787 | 82,539 | ||
| 2019-03-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Shares withheld for taxes | −2,012 | $1.57 | $3K | 80,527 |
| 2019-03-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise · Restricted Stock Unit | −6,787 | 0 | ||
| 2019-03-01 | Lamothe Jeffrey G. SVP and CFO | Option exercise | +7,318 | 77,194 | ||
| 2019-03-01 | Lamothe Jeffrey G. SVP and CFO | Shares withheld for taxes | −2,170 | $1.57 | $3K | 75,024 |
| 2019-03-01 | Lamothe Jeffrey G. SVP and CFO | Option exercise · Restricted Stock Unit | −7,318 | 0 | ||
| 2019-03-01 | Gross Jane A See Remarks | Option exercise | +9,138 | 112,293 | ||
| 2019-03-01 | Gross Jane A See Remarks | Shares withheld for taxes | −2,710 | $1.57 | $4K | 109,583 |
| 2019-03-01 | Gross Jane A See Remarks | Option exercise · Restricted Stock Unit | −9,138 | 0 | ||
| 2019-03-01 | Adelman Michael SVP, Commercial Operations | Option exercise | +7,318 | 72,821 | ||
| 2019-03-01 | Adelman Michael SVP, Commercial Operations | Shares withheld for taxes | −2,395 | $1.57 | $4K | 70,426 |
| 2019-03-01 | Adelman Michael SVP, Commercial Operations | Option exercise · Restricted Stock Unit | −7,318 | 0 | ||
| 2019-02-28 | White Marvin L President and CEO | Grant or award · Stock Option (right to buy) | +151,600 | 151,600 | ||
| 2019-02-28 | Stromatt Scott C Chief Medical Officer and SVP | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 | ||
| 2019-02-28 | Mitchell Shawnte SVP, GC and Corporate Affairs | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 | ||
| 2019-02-28 | Maddux Randy Joe SVP Operations, CMO | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 | ||
| 2019-02-28 | Lamothe Jeffrey G. SVP and CFO | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 | ||
| 2019-02-28 | Gross Jane A See Remarks | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 |
Page 20 of 27 · 523 trades